Structure of Irbesartan CAS 138402-11-6

Irbesartan CAS 138402-11-6

/in , , /by

Identification
Properties
Safety Data
Specifications & Other Information
Links

Identification

CAS Number

138402-11-6

Name

Irbesartan

Synonyms

1,3-Diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]- [ACD/Index Name]
1,3-diazaspiro4.4non-1-en-4-one, 2-butyl-3-2′-(1H-tetrazol-5-yl)1,1′-biphenyl-4-ylmethyl-
138402-11-6 [RN]
2-Butyl-3-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-1,3-diazaspiro[4.4]non-1-en-4-one
2-Butyl-3-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-on [German] [ACD/IUPAC Name]
2-Butyl-3-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one [ACD/IUPAC Name]
2-Butyl-3-{[2′-(1H-tétrazol-5-yl)-4-biphénylyl]méthyl}-1,3-diazaspiro[4.4]non-1-én-4-one [French] [ACD/IUPAC Name]
2-Butyl-3-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-on [German]
2-butyl-3-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one
2-butyl-3-{[2′-(1H-tétrazol-5-yl)biphényl-4-yl]méthyl}-1,3-diazaspiro[4.4]non-1-én-4-one [French]
7229
Irbesartan [INN] [JAN] [USAN] [Wiki]
J0E2756Z7N
[3H]irbesartan
[138402-11-6]
1216883-23-6 [RN]
2-?BUTYL-?3-?[[2′-?(2H-?TETRAZOL-?5-?YL)[1,?1′-?BIPHENYL]-?4-?YL]METHYL]-?1,?3-?DIAZASPIRO[4.4]NON-?1-?EN-?4-?ONE
2-butyl-3-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one
2-butyl-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one
2-Butyl-3-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-1,3-diazaspiro(4.4)non-1-en-4-one
2-Butyl-3-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
2-butyl-3-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
2-Butyl-3-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
2-butyl-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
2-Butyl-3-[2′-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]1,3-diaza-spiro[4.4]non-1-en-4-one
2-Butyl-3-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1,3-diaza-spiro[4.4]non-1-en-4-one
2-Butyl-3-[2′-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1,3-diaza-spiro[4.4]non-1-en-4-one
2-butyl-3-{[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one
2-n-butyl-3-((2′-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one
3-((2-(1h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one
3-((2-(1h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)-methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one
3-((2′-(1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one
3-((2′-(1H-Tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)-methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one
3-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one
3-((2′-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one
3-((2`-(1H-Tetrazol-5-yl)-[1,1`-biphenyl]-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one
3-butyl-2-((4-(2-(2h-tetrazol-5-yl)phenyl)phenyl)methyl)-2,4-diazaspiro(4.4)non-3-en-1-one
3-Butyl-2-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,4-diazaspiro[4.4]non-3-en-1-one
6620400 [Beilstein]
8-butyl-7-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]-7,9-diazaspiro[4.4]non-8-en-6-one
8-butyl-7-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-7,9-diazaspiro[4.4]non-8-en-6-one
Aprovel
Aprovel®
Aprovel®|Avapro®|SR 47436
AVALIDE
Avapro [Wiki]
Avapro®
Avapro;SR-47436; BMS-186295
BMS-186295, SR-47436
BR-57149
C081309
C25H28N6O
HM2950270
irbesartan, ??? 98.0%
IRBESARTAN-D4
Irbesartan-d7
IRBESARTIN
Karvea
MFCD00864464 [MDL number]
MFCD18384966
Pharmakon1600-01504259
TL8000875
UNII:J0E2756Z7N
UNII-J0E2756Z7N

Molecular Structure

Structure of Irbesartan CAS 138402-11-6

Structure of Irbesartan CAS 138402-11-6

SMILES

CCCCC1=NC2(CCCC2)C(=O)N1Cc3ccc(cc3)c4ccccc4c5[nH]nnn5

StdInChI

InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)

StdInChIKey

YOSHYTLCDANDAN-UHFFFAOYSA-N

Molecular Formula

C25H28N6O

Molecular Weight

428.54

MDL Number

MFCD00864464

Safety Data

RIDADR

NONH for all modes of transport

WGK Germany

3

Specifications and Other Information of Our Irbesartan CAS 138402-11-6

Standard

Enterprise standard

GMP

CFDA

Basic Patent Situation

US expiry date20120330
EU expiry dateWITHDRAWN
JP expiry date20160320

Package

According to customer requirements to packaging

Storage

Under the room temperature and away from light

Application

Used as the Angiotensin II Receptor Antagonist

Links

This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/irbesartan-cas-138402-11-6/